FI953423L - Temotsolomidin tehostaminen ihmisten kasvainsoluissa - Google Patents

Temotsolomidin tehostaminen ihmisten kasvainsoluissa Download PDF

Info

Publication number
FI953423L
FI953423L FI953423A FI953423A FI953423L FI 953423 L FI953423 L FI 953423L FI 953423 A FI953423 A FI 953423A FI 953423 A FI953423 A FI 953423A FI 953423 L FI953423 L FI 953423L
Authority
FI
Finland
Prior art keywords
temozolomide
enhancement
tumor cells
human tumor
human
Prior art date
Application number
FI953423A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI953423A7 (fi
FI953423A0 (fi
Inventor
John Colin Baer
Azadeh Alison Freeman
Edward Stuart Newlands
Amanda Jean Watson
Joseph Anthony Rafferty
Geoffrey Paul Margison
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Publication of FI953423A0 publication Critical patent/FI953423A0/fi
Publication of FI953423A7 publication Critical patent/FI953423A7/fi
Publication of FI953423L publication Critical patent/FI953423L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI953423A 1993-01-14 1994-01-13 Temotsolomidin tehostaminen ihmisten kasvainsoluissa FI953423L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US475493A 1993-01-14 1993-01-14
PCT/GB1994/000065 WO1994015615A1 (en) 1993-01-14 1994-01-13 Potentiation of temozolomide in human tumour cells

Publications (3)

Publication Number Publication Date
FI953423A0 FI953423A0 (fi) 1995-07-13
FI953423A7 FI953423A7 (fi) 1995-08-23
FI953423L true FI953423L (fi) 1995-08-23

Family

ID=21712364

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953423A FI953423L (fi) 1993-01-14 1994-01-13 Temotsolomidin tehostaminen ihmisten kasvainsoluissa

Country Status (20)

Country Link
EP (2) EP0679086A1 (cs)
JP (1) JPH08505615A (cs)
KR (1) KR100352046B1 (cs)
CN (1) CN1277541C (cs)
AU (1) AU5838494A (cs)
CA (1) CA2153775C (cs)
CZ (1) CZ286550B6 (cs)
FI (1) FI953423L (cs)
HU (1) HUT72665A (cs)
IL (1) IL108328A (cs)
MX (1) MX9400434A (cs)
MY (1) MY116474A (cs)
NO (1) NO952781L (cs)
PL (1) PL175842B1 (cs)
RU (1) RU2148401C1 (cs)
SK (1) SK282452B6 (cs)
TW (1) TW414710B (cs)
UA (1) UA29466C2 (cs)
WO (1) WO1994015615A1 (cs)
ZA (1) ZA94248B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731304A (en) * 1982-08-23 1998-03-24 Cancer Research Campaign Technology Potentiation of temozolomide in human tumour cells
US5942247A (en) * 1996-07-31 1999-08-24 Schering Corporation Method for treating pediatric high grade astrocytoma including brain stem glioma
US5939098A (en) * 1996-09-19 1999-08-17 Schering Corporation Cancer treatment with temozolomide
US6251886B1 (en) 1998-12-07 2001-06-26 Schering Corporation Methods of using temozolomide in the treatment of cancers
WO2000033823A2 (en) * 1998-12-07 2000-06-15 Schering Corporation Methods of using temozolomide in the treatment of cancers
US6465448B1 (en) * 1999-08-13 2002-10-15 Case Western Reserve University Methoxyamine potentiation of temozolomide anti-cancer activity
US6635677B2 (en) 1999-08-13 2003-10-21 Case Western Reserve University Methoxyamine combinations in the treatment of cancer
DE60321450D1 (de) * 2002-02-22 2008-07-17 Schering Corp Pharmazeutische zubereitungen von antineoplastischen wirkstoffen, insbesondere temozolomid, verfahren zu ihrer herstellung und deren verwendung
EP2431385A3 (en) * 2002-05-31 2012-07-04 Morphotek, Inc. Combination therapy with chlorotoxin
CN100366249C (zh) * 2002-09-29 2008-02-06 天津帝士力投资控股集团有限公司 一种替莫唑胺控释给药系统
CN1752088A (zh) * 2004-09-22 2006-03-29 天津市金士力药物研究开发有限公司 含有替莫唑胺酯的药用组合物
CN100402091C (zh) * 2005-02-03 2008-07-16 山东蓝金生物工程有限公司 一种抗癌药物组合物
CN100350974C (zh) * 2005-02-03 2007-11-28 山东蓝金生物工程有限公司 一种抗癌药物组合物
CN100350975C (zh) * 2005-02-03 2007-11-28 山东蓝金生物工程有限公司 抗癌药物组合物
CN100431605C (zh) * 2005-02-03 2008-11-12 山东蓝金生物工程有限公司 一种抗癌药物组合物
GB0502573D0 (en) * 2005-02-08 2005-03-16 Topotarget As Therapeutic compounds
RU2318509C2 (ru) * 2006-02-10 2008-03-10 Всеволод Иванович Киселев Твердая лекарственная форма дииндолилметана для лечения неопластических заболеваний
WO2008022535A1 (fr) * 2006-08-09 2008-02-28 Tian Jin Tasly Group Co., Ltd. Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
AU2009246142A1 (en) 2008-05-15 2009-11-19 Transmolecular, Inc. Treatment of metastatic tumors
CA2788824C (en) 2010-02-04 2019-03-12 Morphotek, Inc. Chlorotoxin polypeptides and conjugates and uses thereof
AU2011253424B2 (en) 2010-05-11 2016-02-04 Fred Hutchinson Cancer Center Chlorotoxin variants, conjugates, and methods for their use
CN103169664B (zh) * 2011-12-25 2015-04-22 复旦大学 一种rgd肽修饰的双层载药纳米粒及其制备方法
CA2913127A1 (en) 2012-12-10 2014-06-19 Fred Hutchinson Cancer Research Center Methods for screening
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
CA3021011A1 (en) 2016-04-15 2017-10-19 Blaze Bioscience, Inc. Methods of treating breast cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352669A (en) * 1990-03-13 1994-10-04 The Of The United States Of America As Represented By The Department Of Health And Human Services O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O6 -alkylguanine-DNA alkyltransferase depleting activity

Also Published As

Publication number Publication date
UA29466C2 (uk) 2000-11-15
EP0922458A1 (en) 1999-06-16
MY116474A (en) 2004-02-28
CN1277541C (zh) 2006-10-04
HUT72665A (en) 1996-05-28
WO1994015615A1 (en) 1994-07-21
KR960700063A (ko) 1996-01-19
MX9400434A (es) 1994-07-29
SK89295A3 (en) 1996-06-05
IL108328A (en) 2010-05-31
EP0679086A1 (en) 1995-11-02
ZA94248B (en) 1994-07-13
CZ179795A3 (en) 1996-04-17
CZ286550B6 (cs) 2000-05-17
AU5838494A (en) 1994-08-15
CA2153775A1 (en) 1994-07-21
HU9502117D0 (en) 1995-09-28
JPH08505615A (ja) 1996-06-18
KR100352046B1 (ko) 2003-09-03
NO952781L (no) 1995-09-13
CA2153775C (en) 2000-11-14
CN1117711A (zh) 1996-02-28
PL175842B1 (pl) 1999-02-26
RU2148401C1 (ru) 2000-05-10
FI953423A7 (fi) 1995-08-23
PL309915A1 (en) 1995-11-13
FI953423A0 (fi) 1995-07-13
IL108328A0 (en) 1994-04-12
SK282452B6 (sk) 2002-02-05
NO952781D0 (no) 1995-07-13
TW414710B (en) 2000-12-11

Similar Documents

Publication Publication Date Title
FI953423L (fi) Temotsolomidin tehostaminen ihmisten kasvainsoluissa
FI954416L (fi) Kehon solujen stimulointi elektromagneettisen säteilyn avulla
NO942283L (no) Pyrofeoforbider og deres anvendelse i fotodynamisk terapi
BR9406209A (pt) Derivados heterociclicos no tratamento de isquemia e doenças relacionadas
FI955911A7 (fi) Pyratsolopyrimidinonit impotenssin hoidossa
PT1028954E (pt) Imidazoles substituidos uteis no tratamento de doencas inflamatorias
DE69433168D1 (de) In vitro vermehrung von stammzellen
IT1225148B (it) Liberazione prolungata e controllata di peptidi insolubili in acqua
FI955709L (fi) Indolokarbatsolijohdannaisten käyttö eturauhasen patologisten tilojen hoidossa
EP0204597A3 (en) Use of alfuzosine in the treatment of urinary affections
HUP9801634A3 (en) Genetically modified cells and their use in prevention or therapy of disease
IL126768A0 (en) Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
DE69331105D1 (de) Verwendung von thioureleyne und thiabendazol in auto immunbedingten und entzündlichen hauterkrankungen
FI924475A7 (fi) Trinitrobentseenien tai karmiinihapon käyttö syövän ja virusperäisten sairauksien hoidossa
NO970257D0 (no) Bestemmelse av tonisk ovarie-östrogen sekresjon i utvidede terapeutiske regimer
ZA969147B (en) Application of the gax protein to the treatment of cancer
DE59306085D1 (de) Haar- und körperbehandlungsmittel
FI901876A7 (fi) Epätäydelliset hepadnavirukset, rokotteita tuottavat solulinjat sekä m aksan sairauksien hoito
GB9721075D0 (en) Materials and methods relating to the stimulation of cells
KR950005392U (ko) 인체의 안면과 뒷머리 방한 덮개
AU6371198A (en) Potentiation of temozolomide in human tumour cells
SI1011649T1 (en) Use of endipalene in the treatment of psoriasis
SE8604881D0 (sv) Alkylglycerolernas effekt vid cancerterapi
IT1283937B1 (it) Procedimento per il trattamento dello stirene per ottenere caratteristiche di piroresistenza ed in particolare per il

Legal Events

Date Code Title Description
FD Application lapsed